WellGen, Inc.
WellGen’s mission is to discover and develop Medical Foods for inflammation-based diseases using natural products that are safe. Medical Foods, as defined by FDA are formulated to be consumed by patients under the supervision of a physician and intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.
Since the end of 2016, WellGen has signed a license agreement with Rutgers University and is currently working on a sub-licensing agreement with its joint venture partner, a US-based sports beverage company. The joint venture has developed WorkOut TeaTM, the first true performance tea on the market. The functional beverage market has been expanding rapidly in recent years and we believe that WorkOut Tea’s clinically tested and proven benefits should help it stand out from the crowd. WellGen is focused on the success of this functional beverage as we continue to explore distribution channels in the mid-west of the United States, with the possibility of expanding to other US markets and beyond. WellGen’s proprietary Black Tea Extract is scientifically derived and the clinical trial demonstrated improved performance and recovery benefits such as a reduction in muscle soreness and reduced recovery time.
Management
Robert J. Bertoldi- Acting Chief Executive Officer
Board of Directors
Richard C.E. Morgan - (Chairman) Chief Executive Officer, Amphion Innovations
Richard Laster - (Vice Chairman) Management Consultant, former Chief Executive Officer, DNA Plant Technology Corp., EVP, General Foods, President, Maxwell House Coffee
Robert J. Bertoldi - President and Chief Financial Officer, Amphion Innovations
Irwin Engelman - Former Chief Financial Officer, General Foods Corp.
Scott Korman - President, Nashone Inc.
Dr. Laura Philips - Former Chief Operating Officer, NexGenix Pharmaceuticals; former Executive, Corning, Inc.
Dr. William R. Sharp Partner - GNP LLC
